covermagazine_logo
Sign in Join
    • My account
    • Sign out
  • You are currently accessing Cover Magazine via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
logo
  • logo

    Search Cover

  • News
  • Topics

    Select a topic from the list below

    • Life
    • Critical illness
    • Income protection
    • Health
    • Employee benefits
    • Regulation
    • Diversity
    • Mental health
  • Mortgages
  • COVER Review
  • Partner Insight

    Latest Content, produced in association with our partners:

    • 3MW with Aviva's Ben Whatling
  • Events
  • COVER Classroom
  • More

    Content by subject

    • Business protection
    • Cashplans
    • Individual income protection
    • Individual critical illness
    • Group critical illness
    • Group income protection
    • Group life
    • Health
    • International PMI
    • LTC

    Featured content

    • Access to Insurance
    • Partner Insight
    • EBooks

    Events

    • Women in Protection and Health Awards 2025
    • Customer Care Awards 2025

    About

    • Cover Magazine
    • Cameron Roberts
    • Jaskeet Briah
  • Searchlogo

    Search Cover

    x
Join Sign in
 
    • My account
    • Sign out
  • You are currently accessing Cover Magazine via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
    • Sign in

cancer

PMI

Government rebutted as cancer cures soar

The government's assertion that the National Health Service is inefficient and ineffective in treating cancer has been challenged by academics.

clock 08 November 2011 • 1 min read

Individual PMI

Aviva extends cancer cover to include non-NHS drugs

Aviva has overhauled its cancer coverage for both individual and group private medical insurance (PMI) schemes.

clock 31 October 2011 • 2 min read

Income Protection

Welfare reform could have 'catastrophic' effect on cancer patients - MacMillan

Cancer patients already severely struggling with financial difficulties because of their illness could be hit with "catastrophic" effects if welfare reform proceeds, MacMillan Cancer Support has warned.

clock 24 October 2011 • 2 min read

PMI

Bupa adds NHS cancer top-up

Bupa has introduced an option to tailor cancer coverage around NHS diagnosis and treatment provision.

clock 24 October 2011 • 1 min read

Critical Illness

Aviva enters partial payments market for CI

Aviva has added the first partial payments to its critical illness (CI) policy and halved the length of time for a Multiple Sclerosis (MS) claim.

clock 17 October 2011 • 1 min read

PMI

Overprescribing cancer drugs 'not tenable way forward' - experts

Cancer experts have concluded that countries in the developed world are overprescribing very expensive drugs that produce marginal benefit.

clock 27 September 2011 • 2 min read

PMI

Exeter Family Friendly unveils modular PMI plan

Exeter Family Friendly has launched a new modular private medical insurance (PMI) product.

clock 21 September 2011 • 1 min read

Adviser / Broking

The ten most common underwriting queries (and answers)

Not only will the needs of each and every client who needs a protection policy differ, but advisers also have to factor in the different underwriting processes of providers...

clock 09 September 2011 • 3 min read

PMI

Cancer fund has led to 'devastating divide' in treatment

The Cancer Drugs Fund has led to a ‘devastating divide' in access to treatment between England and other home nations, according to a cancer charity.

clock 30 August 2011 • 1 min read

PMI

NICE rejects breast cancer drug

The National Institute for Health and Clinical Excellence (NICE) has rejected another cancer drug for the NHS due to its cost.

clock 22 August 2011 • 2 min read
515253
  • Contact Us
  • Marketing Solutions
  • About Incisive Media
  • Privacy Settings
  • Terms & Conditions
  • Policies
  • Careers
FOLLOW US
Incisive Media

© Incisive Business Media Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR. Registered in England and Wales with company registration number 09178013. Part of Arc network, www.arc-network.com

DIGITAL PUBLISHER OF THE YEAR
right wallpaper ad
Loading.gif?page type=listing page&tag=cancer